ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $212,000 | -3.6% | 40,957 | -32.8% | 0.00% | – |
| Q1 2019 | $220,000 | -49.3% | 60,948 | -13.9% | 0.00% | – |
| Q4 2018 | $434,000 | +53.9% | 70,766 | +46.4% | 0.00% | – |
| Q3 2018 | $282,000 | -33.8% | 48,343 | -51.7% | 0.00% | – |
| Q2 2018 | $426,000 | -1.4% | 100,122 | +2.4% | 0.00% | – |
| Q1 2018 | $432,000 | +19.3% | 97,819 | +42.3% | 0.00% | – |
| Q4 2017 | $362,000 | -10.6% | 68,758 | +4.1% | 0.00% | – |
| Q3 2017 | $405,000 | -37.1% | 66,054 | -25.9% | 0.00% | – |
| Q2 2017 | $644,000 | +38.8% | 89,117 | +1.8% | 0.00% | – |
| Q1 2017 | $464,000 | -38.5% | 87,561 | +8.7% | 0.00% | -100.0% |
| Q3 2016 | $754,000 | +170.3% | 80,547 | +82.2% | 0.00% | – |
| Q2 2016 | $279,000 | +106.7% | 44,199 | +81.3% | 0.00% | – |
| Q1 2016 | $135,000 | -83.3% | 24,379 | -83.2% | 0.00% | -100.0% |
| Q4 2015 | $809,000 | +81.0% | 144,989 | +479.0% | 0.00% | – |
| Q4 2014 | $447,000 | +154.0% | 25,040 | +42.9% | 0.00% | – |
| Q3 2014 | $176,000 | – | 17,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |